Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Potential Side Effects : Common side effects include nausea, vomiting, or diarrhea, especially during the initial weeks of treatment
While definitive causal reduction in cancer risk with GLP-1 therapies is not established, the cardiovascular and metabolic benefits of significant weight loss may outweigh theoretical cancer concerns for many patients
The skin is often the last organ to receive nutrients, as the body prioritizes internal organs like the heart and liver
Having weight loss treatment covered by insurance could be a reality with our support, as we work closely with insurers, including Medicare and Medicaid, to promote coverage for medically necessary scenarios
Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal Medicine
US$ 20.01
US$ 26.16
US$ 28.01
